Zobrazeno 1 - 10
of 96
pro vyhledávání: '"PAOLA ORLANDI"'
Autor:
Luigi Coltelli, Giacomo Allegrini, Paola Orlandi, Chiara Finale, Andrea Fontana, Luna Chiara Masini, Marco Scalese, Giada Arrighi, Maria Teresa Barletta, Ermelinda De Maio, Marta Banchi, Elisabetta Fini, Patrizia Guidi, Giada Frenzilli, Sara Donati, Simona Giovannelli, Lucia Tanganelli, Barbara Salvadori, Lorenzo Livi, Icro Meattini, Ilaria Pazzagli, Marco Di Lieto, Mirco Pistelli, Virginia Casadei, Antonella Ferro, Samanta Cupini, Francesca Orlandi, Damiana Francesca, Giulia Lorenzini, Leonardo Barellini, Alfredo Falcone, Alessandro Cosimi, Guido Bocci
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-9 (2022)
Abstract To investigate pharmacogenetic interactions among VEGF-A, VEGFR-2, IL-8, HIF-1α, EPAS-1, and TSP-1 SNPs and their role on progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with bevacizumab plus first-line pa
Externí odkaz:
https://doaj.org/article/ddb3a8574ac74c6f9118cd6ec4935bea
Autor:
Federico Cucchiara, Giacomo Luci, Noemi Giannini, Filippo Sean Giorgi, Paola Orlandi, Marta Banchi, Antonello Di Paolo, Francesco Pasqualetti, Romano Danesi, Guido Bocci
Publikováno v:
Pharmacological Research, Vol 181, Iss , Pp 106290- (2022)
Glioblastoma multiforme (GBM) is an aggressive brain tumor, often occurring with seizures managed with antiepileptic drugs, such as levetiracetam (LEV). This study is aimed at associating progression-free survival (PFS) and overall survival (OS) of G
Externí odkaz:
https://doaj.org/article/53635defdfb448509408cfa093585276
Autor:
Paola Orlandi, Anna Solini, Marta Banchi, Maurizia Rossana Brunetto, Dania Cioni, Lorenzo Ghiadoni, Guido Bocci
Publikováno v:
Pharmaceuticals, Vol 14, Iss 10, p 995 (2021)
Non-alcoholic fatty liver disease is the most common liver disorder worldwide, and its progressive form non-alcoholic steatohepatitis (NASH) is a growing cause of liver cirrhosis and hepatocellular carcinoma (HCC). Lifestyle changes, which are capabl
Externí odkaz:
https://doaj.org/article/71df96394f204441b054579d08809561
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
The purpose of this study was to examine pazopanib/topotecan combination activity vs. pazopanib monotherapy on anaplastic thyroid cancer (ATC) cells. Proliferation analyses were performed on ATC cell lines administered for 72 h with pazopanib and top
Externí odkaz:
https://doaj.org/article/3785fc5d40084486a23b6634ff285f9a
Autor:
Guido Bocci, Anna Fioravanti, Paola Orlandi, Teresa Di Desidero, Gianfranco Natale, Giovanni Fanelli, Paolo Viacava, Antonio Giuseppe^Naccarato, Giulio Francia, Romano Danesi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 14, Iss 9, Pp 833-845 (2012)
AIMS: To evaluate the antitumor and antiangiogenic activity of metronomic ceramide analogs and their relevant molecular mechanisms. METHODS: Human endothelial cells [human dermal microvascular endothelial cells and human umbilical vascular endothelia
Externí odkaz:
https://doaj.org/article/424e515d3d2340ba94e2741890af427b
Autor:
Bastianina Canu, Anna Fioravanti, Paola Orlandi, Teresa Di Desidero, Greta Alì, Gabriella Fontanini, Antonello Di Paolo, Mario Del Tacca, Romano Danesi, Guido Bocci
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 13, Iss 3, Pp 217-229 (2011)
Aims: To demonstrate the synergistic antiproliferative and proapoptotic activity of irinotecan and axitinib in vitro and the improvement of the in vivo effects on angiogenesis and pancreatic cancer. Methods: Proliferation and apoptotic assays were pe
Externí odkaz:
https://doaj.org/article/4078a82823e84430ba68043b0887298e
Autor:
Stefano Lazzeri, Paola Orlandi, Michele Figus, Anna Fioravanti, Elisa Cascio, Teresa Di Desidero, Elisa Agosta, Bastianina Canu, Maria Sole Sartini, Romano Danesi, Marco Nardi, Guido Bocci
Publikováno v:
The Scientific World Journal, Vol 2012 (2012)
In this prospective, case-control genetic study, 120 consecutive neovascular age-related macular degeneration (AMD) cases and 78 controls were enrolled. Two SNPs (rs2071559 and rs1870377) of VEGF-A receptor-2 (VEGFR-2) gene were analyzed with the tec
Externí odkaz:
https://doaj.org/article/cc028a1990064637ac9ec434c8085fca
Autor:
Guido Bocci, Sabrina Pelliccia, Paola Orlandi, Matteo Caridi, Marta Banchi, Gerardo Musuraca, Arianna Di Napoli, Maria Paola Bianchi, Caterina Patti, Paola Anticoli-Borza, Roberta Battistini, Ivana Casaroli, Tiziana Lanzolla, Agostino Tafuri, Maria Christina Cox
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 7162
The upfront treatment of very elderly and frail patients with diffuse large B-cell lymphoma (DLBCL) is still a matter of debate. Herein, we report results of the metronomic all-oral DEVEC [prednisolone/deltacortene®, vinorelbine (VNR), etoposide (ET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87228d38960f0cc851272f9a4b0053bc
https://pubmed.ncbi.nlm.nih.gov/36498736
https://pubmed.ncbi.nlm.nih.gov/36498736
Autor:
Guido Bocci, Paola Orlandi, Maria Laura Manca, Chiara Rossi, Antonio Salvati, Maurizia Rossana Brunetto, Anna Solini
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 20; Pages: 5985
Background: Although liver biopsy remains the gold standard for the diagnosis and the monitoring of liver disease, non-invasive biomarkers have been recently suggested to predict liver disease severity, progression, and response to therapy. We invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::845eb90498e594b0fce7c0f484b1846a
https://pubmed.ncbi.nlm.nih.gov/36294318
https://pubmed.ncbi.nlm.nih.gov/36294318
Autor:
Francesco Pasqualetti, Celeste Giampietro, Nicola Montemurro, Noemi Giannini, Giovanni Gadducci, Paola Orlandi, Eleonora Natali, Paolo Chiarugi, Alessandra Gonnelli, Martina Cantarella, Cristian Scatena, Giuseppe Nicolò Fanelli, Antonio Giuseppe Naccarato, Paolo Perrini, Gaetano Liberti, Riccardo Morganti, Maria Franzini, Aldo Paolicchi, Giovanni Pellegrini, Guido Bocci, Fabiola Paiar
Publikováno v:
Genes; Volume 13; Issue 6; Pages: 1054
Background Systemic immunity and inflammation indexes (SI) derived from blood cells have gained increasing attention in clinical oncology as potential biomarkers that are associated with survival. Materials and methods We tested 12 different SI using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d53afb55199086b7b9be321c9165c3c
https://doi.org/10.3390/genes13061054
https://doi.org/10.3390/genes13061054
